Toxicology Laboratory Industry Analysis in North America

Toxicology Laboratory Demand Outlook in North America (2024 to 2034)

The toxicology laboratory sector in North America garnered US$ 239.2 million in revenue in 2024. By 2034, the toxicology laboratory industry in North America is projected to advance at a CAGR of 11.3%, with a worth of US$ 695.1 million.

It is expected that toxicology laboratory sales in North America are set to grow significantly, mostly due to rising awareness of the significance of toxicological testing. It is anticipated that factors including stricter laws, an increase in the need for drug tests, and technological developments foster North America industry growth for toxicology laboratory. The demand for toxicology laboratory services increases as occupational safety and environmental monitoring gain prominence.

Report Attributes	Details
Toxicology Laboratory Sales in North America (2024E)	US$ 239.2 million
Forecasted Toxicology Laboratory Industry Value (2034F)	US$ 695.1 million
CAGR (2024 to 2034)	11.3%
Opiates/Opioids Segment Growth Rate (2024 to 2034)	13.3%
Reagents and Kits Segment Growth Rate (2024 to 2034)	11.4%
Hair Segment Growth Rate (2024 to 2034)	13.7%
Diagnostic Laboratories Segment Growth Rate (2024 to 2034)	12.4%
United States Industry Share (2034)	72.8%
Canada Industry Share (2034)	18.4%
Key Companies Profiled	Thermo Fisher Scientific, Inc Danaher Corporation Agilent Technologies Alere, Inc. Bio Rad Laboratories Inc. Neogen Corporation Bruker WATERS Redwood Toxicology Laboratory Laboratory Corporation of America ©Holdings (MedTox Laboratories, Inc.)

What Growth Factors Shape the Toxicology Laboratory Landscape in North America?

Toxicology laboratory sales in North America are rising due to rising healthcare spending. Toxicology testing is more in demand as medical facilities invest more in diagnostic services to aid clinical decision-making.

Accurate diagnostic testing, including toxicological testing, is necessary due to the growing trend toward precision medicine to customize treatment regimens based on each patient's unique characteristics. This trend aids the industry growth of toxicology laboratory services in North America.

Toxicology testing is crucial for the prompt and precise identification of dangerous compounds, as evidenced by the rising number of poisoning cases, intentional or not. This factor influences the demand for toxicology laboratory services in North America.

Which Economic Barriers Impede the Progress of Toxicology Laboratory in North America?

Fiscal restrictions and industry volatility in research institutes and healthcare systems restrict the funding for toxicology laboratory services. The toxicology laboratory adoption in North America is adversely affected by this.

Labs operating in the toxicology laboratory sector in North America face difficulties due to strict rules and compliance specifications. Rules that are altered or new testing guidelines that are implemented raise the costs and complexity of the operation.

Emerging toxicology laboratory manufacturers experience difficulties due to the industry's competitiveness and the possibility of laboratory consolidation. Emerging competitors find it challenging to establish themselves because established laboratories enjoy a better industry position.

Country-wise Analysis

The increased demand for toxicology laboratories results from growing demands in the United States and Canada, the significant North American countries. The United States is expected to possess an enormous 72.8% industry share by 2034, making it the predominant nation in the toxicology laboratory sector.

The growth indicates a growing dependence on toxicology services, reflecting toxicology laboratories' vital role in tackling public health and safety issues and strengthening the industry's popularity in North America.

What are the Key Market Dynamics Propelling the Toxicology Laboratory in the United States?

“Growing Demand for Drug Testing Services Propels the Market Expansion of Toxicology Laboratory in The United States.”

Attributes	Details
United States Market CAGR	11.0%
United States Market Size (2024)	US$ 178 million

The United States toxicology laboratory industry is expanding and innovating due to the growing need for personalized medication. Toxicology laboratory expansion in the United States is driven by growing public awareness of environmental contaminants.

Modern technology like mass spectrometry has been adopted, a significant trend changing the toxicology testing scene in the United States. It is anticipated that the United States is going to hold a 74.6% industry share of toxicology laboratory in 2024.

How Prominent is the Toxicology Laboratory Sector in Canada Market?

“Advancements In Analytical Technologies Spur Innovation in Canada's Toxicology Testing Sector.”

Attributes	Details
Canada Market CAGR	11.8%
Canada Market Size (2024)	US$ 42 million

The toxicology laboratory industry in Canada is expanding steadily due to increased emphasis on occupational health and safety at work. Progress in toxicological testing is driven by government efforts that support research on new toxins in Canada.

The demand for toxicological testing services is stimulated by the increasing incidence of drug usage in the Canada industry. Canada is expected to possess a 17.5% share in the toxicology laboratory industry in 2024.

What Factors Shape the Mexico Toxicology Laboratory Industry?

“Telemedicine Integration and Digital Reporting Solutions Gain Traction in Mexico's Toxicology Laboratories.”

Attributes	Details
Mexico Market CAGR	9.1%
Mexico Market Size (2024)	US$ 19 million

Due to growing awareness of food safety and contamination issues, the demand for toxicology laboratory in Mexico is expanding significantly. Specialized laboratory growth is influenced by Mexico's increasing emphasis on forensic toxicology.

Mexico's widespread adoption of fast testing techniques makes quick and effective toxicological analysis for various applications possible. The toxicology laboratory industry is expected to witness Mexico possess a 7.9% share in 2024.

Category-wise Outlook

Based on the drug class, the amphetamines segment is estimated to hold a 27.1% industry share by 2034. Simultaneously, the opiates/opioids segment is anticipated to secure a noteworthy 21.0% share by 2034, contributing significantly to the industry.

Based on product, the reagents and kits segment marks its dominance, with a share of 57.5% by 2034. Demand for instruments also remains significant, after reagents and kits, with a share of 42.5% by 2034

Based on sample, the urine segment leads with a share of 52.7% by 2034. It is followed by oral fluids segment acquiring a share of 24.3% by 2034.

What Escalates the Amphetamines Segment to Lead in Toxicology Labs?

“Increased Awareness of Amphetamine-Related Health Risks Boosts Demand.”

Amphetamines	Details
Segment Size (2024)	US$ 64 million
Segment CAGR (2024 to 2034)	11.4%

Opiates/Opioids	Details
Segment Size (2024)	U$ 41.9 million
Segment CAGR (2024 to 2034)	13.3%

The increasing adoption of amphetamines for a variety of medical issues boosts toxicology laboratory demand. Toxicology testing is increasingly necessary as amphetamine usage and its derivatives become prevalent.

Constant improvements in medications related to amphetamines require close observation, which increases industry share. In 2024, the amphetamines category is projected to account for 27.1% of the toxicology laboratory industry.

What Makes the Reagents and Kits Segment Stand Out?

“Reagents and Kits Segment Has Gained Popularity Due to Its Cost-Effectiveness and Quick Turnaround Time.”

Reagents and Kits	Details
Segment Size (2024)	US$ 135.9 million
Segment CAGR (2024 to 2034)	11.4%

Instruments	Details
Segment Size (2024)	U$ 103.0 million
Segment CAGR (2024 to 2034)	11.1%

The adoption of reagents and kits in toxicity testing is facilitated by their simplicity of integration into current laboratory workflows and protocols. The reagents and kits category continues to establish a foothold due partly to ongoing innovations and developments in toxicology testing procedures.

The ongoing demand for reagents and kits is fueled by their necessity as consumables for toxicological testing. In 2024, reagents and kits segment is expected to contribute for 56.8% of the industry share.

What Makes Urine the Leading Segment in Toxicology Lab Market?

“The Simplicity and Cost-Effectiveness of Urine Sample Contribute to Its Dominance in the North America Market.”

Urine	Details
Segment Size (2024)	US$ 137 million
Segment CAGR (2024 to 2034)	10.3%

Oral Fluids	Details
Segment Size (2024)	U$ 51.5 million
Segment CAGR (2024 to 2034)	12.6%

Urine sample collection and standardized testing protocols help explain their prevailing industry dominance in toxicology laboratory. Urine samples are easy to gather and handle, which increases their visibility in toxicological testing and helps them maintain their leading industry position.

Urine collection is non-invasive, improving patient compliance and making frequent testing easier, strengthening its industry leadership in toxicology laboratories. It is anticipated that the urine sample segment is expected to represent 56.8% of the industry share in 2024.

Competitive Analysis

Key players in the North America toxicology laboratory market include Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Alere, Inc., Bio Rad Laboratories Inc., Neogen Corporation, Bruker, Redwood Toxicology Laboratory. Prominent toxicology laboratory producers in North America are adding new products to strengthen their core capabilities. The toxicology laboratory vendors in North America are concentrating on making modifications to achieve optimal outcomes in the least period.

The toxicology laboratory manufacturers in North America expand their manufacturing capabilities and industry share to satisfy the rising demand for toxicological services. To get consumers to embrace an invention, different innovations are positioned to emphasize their USP.

Notable Breakthroughs and Innovations :

• Synaffix B.V., which focuses on commercializing its clinical-stage technological platform for the development of ADCs, was bought by Lonza, a North American manufacturing partner to the pharmaceutical, biotech, and nutraceutical industries, in June 2023. This aids the company in growing its footprint in North America.
• BML and Labcorp Drug Development announced in May 2023 that they intend to expand their clinical laboratory testing capabilities in Japan. This contributes to the company's product portfolio strengthening.
• A research collaboration and commercial license agreement were announced in December 2022 by Merck KGaA, a leading science and technology company, and Mersana Therapeutics, Inc., located in Cambridge, Massachusetts, the United States. The agreement aims to discover novel antibody-drug conjugates that target up to two targets by utilizing Mersana's proprietary Immunosynthen STING-agonist ADC platform.
• Thermo Fisher Scientific Inc. declared in October 2022 that it would be growing its laboratory operations in Highland Heights, Kentucky, to assist clients in providing patients with life-altering medications. The present facility offers biopharma clients top-notch laboratory services to expedite drug development. This aided the corporation in growing its clinical diagnostics division and industry share in North America.
• PerkinElmer, Inc. unveiled the GC 2400 Platform in June 2022, focusing on innovation for a healthier world. This sophisticated automated gas chromatography (GC), headspace sampler, and GC/mass spectrometry (GC/MS) solution assist laboratory teams in streamlining lab operations, achieving precise results, and carrying out more flexible monitoring.

Segmentation of Toxicology Laboratory Industry in North America

• By Drug Class :

  • Alcohol
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Opiates/Opioids
  • Tricyclic Antidepressants
  • Z Drugs

• By Product :

  • Instruments
  • Reagents and Kits

• By Sample :

  • Urine
  • Blood
  • Hair
  • Oral Fluids

• By End User :

  • Hospitals and Trauma Centers
  • Forensic Laboratories
  • Diagnostic Laboratories
  • Rehabilitation Centers

• By Country :

  • United States
  • Canada